STAGE IV ANAL CANCER AJCC V8
Clinical trials for STAGE IV ANAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV ANAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV ANAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy combo shows promise in advanced anal cancer trial
Disease control OngoingThis study tests whether adding the immunotherapy drug nivolumab to standard chemotherapy works better than chemotherapy alone for people with anal cancer that has spread or cannot be removed. About 205 adults with this type of cancer will receive either the combination or just c…
Matched conditions: STAGE IV ANAL CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Immunotherapy combo shows promise for tough anal cancer
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in people with anal cancer that has spread and not responded to prior treatment. The goal is to see if these drugs can shrink tumors or slow cancer growth. About 143 participants will receive either nivolumab alo…
Matched conditions: STAGE IV ANAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:24 UTC